:be Aktie
WKN DE: A3CWWB / ISIN: AT0000A2SGH0
15.11.2024 11:45:00
|
Where Will CRISPR Therapeutics Be in 3 Years?
CRISPR Therapeutics (NASDAQ: CRSP) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. Now, its challenge is to build on its prior successes to become a biotech powerhouse and prove to investors that it isn't a one-trick pony.The next three years will be critical for both of those things. Here's what to expect.By late 2027, CRISPR will be a larger biotech, with much more revenue, more collaborators, and a much bigger pipeline -- but still probably not any profits.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu :be AG Inhaber-Aktmehr Nachrichten
Analysen zu :be AG Inhaber-Aktmehr Analysen
Aktien in diesem Artikel
CRISPR Therapeutics AG | 33,40 | -0,60% |
|